Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 19.06.2025       Verve Group SE

Company Name: Verve Group SE ISIN: SE0018538068   Reason for the research: Recommendation: Kaufen from: 19.06.2025 Target price: €5,80 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) veröffentlic [ … ]
Wed, 18.06.2025       https://research-hub.de/companies/Leifheit AG

Leifheit has revised its FY25 guidance downward amid continued weak consumer demand in key markets. The company now expects full-year revenue to slightly decline compared to 2024’s EUR 259.2m, down from an earlier forecast of 2–4% growth. EBIT guidance was reduced to around 2024 level (EUR 12.1m), mainly due to EUR 3m in oneoff costs related to relocating injection moulding operations from Nassau to Blatná. The consolidation at Blatná is part of a broader production optimization strategy, aiming to deliver annual cost savings of about EUR 2m starting in H2 25, although upfront investments will imapct profitability in H1 25. Free cash flow guidance has also been revised downward to a mid-single-digit EURm range. Despite near-term challenges, the company’s mid-term outlook remains positive, supported by operational efficiency, a strong balance sheet, and a shareholder-friendly dividend policy. mwb research’s analysts have revised their estimates downward and slightly reduced their PT to EUR 29.00 (from EUR 30.00) but maintain their BUY rating. The full update can be downloaded under: https://research-hub.de/companies/leifheit-ag
Wed, 18.06.2025       https://research-hub.de/companies/MTU Aero Engines AG

MTU Aero Engines has upgraded its 2025 guidance, now expecting EUR 8.6–8.8bn in revenue and adjusted EBIT growth of 20–25%, driven by strong momentum in commercial MRO and OEM segments. The company also provided a bullish 2030 outlook, targeting EU 13–14bn in revenue and 14.5–15.5% EBIT margins. Defense remains a strategic growth lever, while recent investments in LEAP and GEnx MRO capacity support long-term positioning. However, rising FX risk clouds the outlook beyond 2025, as USD exposure becomes increasingly unhedged. With shares up over 30% in four weeks and now trading near fair value, mwb research’s analysts reiterate to HOLD. The analysts revise their price target to EUR 360.00 (from EUR 350.00), reflecting upgraded fundamentals. The full update can be downloaded under https://www.research-hub.de/companies/MTU%20Aero%20Engines%20AG
Wed, 18.06.2025       https://research-hub.de/companies/Fresenius Medical Care AG

At its Capital Markets Day, Fresenius Medical Care (FME) presented its “FME Reignite” strategy, emphasizing operational excellence, innovation, and cultural transformation. Key targets include mid-teens operating margins (excluding special items) by 2030, EUR 1.05bn in cost savings by 2027, and continued investment in high-volume hemodiafiltration technology. The capital framework includes a 30–40% dividend payout and a EUR 1bn share buyback. While the strategy reinforces long-term ambitions and financial discipline, it introduces no new catalysts or disruptive initiatives. As expectations were largely priced in, the event does not justify a re-rating. With only finetuning changes to mwb research’s CAPEX estimates, the analysts reiterate their HOLD rating and maintain the current price target of EUR 52.00. The full update can be downloaded under https://www.research-hub.de/companies/Fresenius%20Medical%20Care
Tue, 17.06.2025       MPH Health Care AG

Company Name: MPH Health Care AG ISIN: DE000A289V03   Reason for the research: Update Recommendation: Kaufen from: 17.06.2025 Target price: €37 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) ver&o [ … ]
Tue, 17.06.2025       Verve Group SE

Company Name: Verve Group SE ISIN: SE0018538068   Reason for the research: Comprehensive update Recommendation: Kaufen from: 17.06.2025 Target price: €6 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068)  [ … ]
Tue, 17.06.2025       Scandinavian Astor Group AB

Company Name: Scandinavian Astor Group AB ISIN: SE0019175274   Reason for the research: Update Recommendation: Buy from: 17.06.2025 Target price: 54.00 Target price on sight of: 12 months Last rating change: Analyst: Henry Wendisch Another deal unlocks opportunities in the Baltics, PT up. Yesterday, Astor announced the acquisiti [ … ]
Tue, 17.06.2025       https://research-hub.de/companies/Mister Spex SE

Mister Spex has revised its FY25 revenue guidance downward to a decline of 10–20%, driven by a significant drop in online sunglasses sales, which fell 37% in Q1 and likely worsened in Q2. Despite the topline pressure, the company maintains its EBIT margin guidance (-5% to -15%) and year-end cash outlook (~EUR 65m), underscoring its focus on profitability and cost discipline. Improvements in unit economics—including an 11% rise in average order value and the successful launch of a subscription model—reflect early gains from the SpexFocus transformation program. mwb research’s analysts reiterate their BUY rating with unchanged PT of EUR 4.00, as Mister Spex remains strategically well-positioned with solid liquidity and improving operational fundamentals. The full update can be downloaded under www.research-hub.de/companies/Mister%20Spex%20SE
Mon, 16.06.2025       Energiekontor AG

Company Name: Energiekontor AG ISIN: DE0005313506   Reason for the research: Update Recommendation: Buy from: 16.06.2025 Target price: 105,00 Euro Target price on sight of: 12 Monate Last rating change: 18.10.2022: Hochstufung von Hinzufügen auf Kaufen Analyst: Dr. Karsten von Blumenthal First Berlin Equity Research hat ein [ … ]
Mon, 16.06.2025       https://research-hub.de/companies/energenta AG

energenta AG is well-positioned to benefit from the EU’s stricter recycling regulations, which mandate up to 30% recycled content in plastics by 2030 and 50% by 2050. By divesting its stake in the mature substitute fuels segment, energenta sharpens its focus on high-quality recyclates and plans to triple capacity in the Regranulates & Compounds segment by 2027. Although near-term profitability may decline, the strategic shift enhances scalability and regulatory alignment. Supported by strong industry expertise, operational depth, and expected demand growth, energenta remains structurally advantaged. mwb research’s analysts confirm their BUY rating with a target price of EUR 3.60. The full update can be downloaded under https://www.research-hub.de/companies/energenta%20AG

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 12.07.2025, Calendar Week 28, 193rd day of the year, 172 days remaining until EoY.